Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89


Why does primary angioplasty not work in registries? Quantifying the susceptibility of real-world comparative effectiveness data to allocation bias.

Sen S, Davies JE, Malik IS, Foale RA, Mikhail GW, Hadjiloizou N, Hughes A, Mayet J, Francis DP.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):759-66. doi: 10.1161/CIRCOUTCOMES.112.966853. Epub 2012 Nov 13.


Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.

Denktas AE, Athar H, Henry TD, Larson DM, Simons M, Chan RS, Niles NW, Thiele H, Schuler G, Ahn C, Sdringola S, Anderson HV, McKay RG, Smalling RW.

JACC Cardiovasc Interv. 2008 Oct;1(5):504-10. doi: 10.1016/j.jcin.2008.06.009.


The acute myocardial infarction with ST segment elevation Udine registry (Come-to-Udine): predictors of 3 years mortality.

Bernardi G, Di Chiara A, Armellini I; Working Group of Area Vasta Udinese.

J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):474-84.


Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age.

de Boer SP, Westerhout CM, Simes RJ, Granger CB, Zijlstra F, Boersma E; Primary Coronary Angioplasty Versus Thrombolysis-2 (PCAT-2) Trialists Collaborators Group.

JACC Cardiovasc Interv. 2010 Mar;3(3):324-31. doi: 10.1016/j.jcin.2009.11.022.


Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool.

Burjonroppa SC, Varosy PD, Rao SV, Ou FS, Roe M, Peterson E, Singh M, Shunk KA.

JACC Cardiovasc Interv. 2011 Jan;4(1):42-50. doi: 10.1016/j.jcin.2010.09.020.


Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes.

Kumbhani DJ, Cannon CP, Fonarow GC, Liang L, Askari AT, Peacock WF, Peterson ED, Bhatt DL; Get With the Guidelines Steering Committee and Investigators.

JAMA. 2009 Nov 25;302(20):2207-13. doi: 10.1001/jama.2009.1715.


Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials.

De Luca G, Verdoia M, Suryapranata H.

Atherosclerosis. 2012 Jun;222(2):426-33. doi: 10.1016/j.atherosclerosis.2012.02.041. Epub 2012 Mar 7. Review.


The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.

Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, French WJ, Tiefenbrunn AJ, Misra VK, Kiefe CI, Barron HV.

N Engl J Med. 2000 May 25;342(21):1573-80.


Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.

Tarantini G, Razzolini R, Napodano M, Bilato C, Ramondo A, Iliceto S.

Eur Heart J. 2010 Mar;31(6):676-83. doi: 10.1093/eurheartj/ehp506. Epub 2009 Nov 27. Review.


Trends in acute myocardial infarction treatment between 1998 and 2007 in a Belgian area (Charleroi).

Collart P, Coppieters Y, Levêque A.

Eur J Prev Cardiol. 2012 Aug;19(4):738-45. doi: 10.1177/1741826711415707. Epub 2011 Jun 27.


Care of acute myocardial infarction in the coronary care units of Piedmont in 2007: results from the 'PRIMA_sweet' region-wide survey.

Steffenino G, Chinaglia A, Noussan P, Alciati M, Bongioanni S, Rolfo C, Soldà PL, Gnavi R, Picariello R, Orlando A; PRIMAsweet investigators.

J Cardiovasc Med (Hagerstown). 2013 May;14(5):354-63. doi: 10.2459/JCM.0b013e32835422f8.


Primary angioplasty and selection bias inpatients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction.

Elad Y, French WJ, Shavelle DM, Parsons LS, Sada MJ, Every NR.

J Am Coll Cardiol. 2002 Mar 6;39(5):826-33.


High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration.

de Boer SP, Barnes EH, Westerhout CM, Simes RJ, Granger CB, Kastrati A, Widimsky P, de Boer MJ, Zijlstra F, Boersma E.

Am Heart J. 2011 Mar;161(3):500-507.e1. doi: 10.1016/j.ahj.2010.11.022.


Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction.

Claeys MJ, de Meester A, Convens C, Dubois P, Boland J, De Raedt H, Vranckx P, Coussement P, Gevaert S, Sinnaeve P, Evrard P, Beauloye C, Renard M, Vrints C.

Arch Intern Med. 2011 Mar 28;171(6):544-9. doi: 10.1001/archinternmed.2011.57.


Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.

De Luca G, Biondi-Zoccai G, Marino P.

Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033. Review.


Coronary care unit and primary percutaneous coronary intervention networks improve the standard of care: reperfusion therapy in ST elevation myocardial infarction in Serbia from 2002 to 2008.

Vasiljevic Z, Mickovski-Katalina N, Krljanac G, Panic G, Putnikovic B, Ostojic M, Stojanovic B, Milanovic S.

J Cardiovasc Med (Hagerstown). 2011 Apr;12(4):300-2. doi: 10.2459/JCM.0b013e328343e9f2. No abstract available.


Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.

Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.

Kardiol Pol. 2007 Jan;65(1):1-10; discussion 11-2. English, Polish.

Supplemental Content

Support Center